ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
243 | (±¹¿Ü)SCI | Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer. |
242 | (±¹³»)SCIE | Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome |
241 | (±¹³»)SCIE | The First Korean Case of High-Molecular-Weight Kininogen Deficiency, With a Novel Variant, c.488delG, in the KNG1 Gene |
240 | (±¹¿Ü)SCI | Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review |
239 | (±¹³»)SCOPUS | Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura |
238 | (±¹¿Ü)±âŸ | Transglutaminase 2 Induces Intrinsic EGFR-TKI Resistance in NSCLC Harboring EGFR Sensitive Mutations |
237 | (±¹¿Ü)SCIE | Analysis of the Association Between MicroRNA Biogenesis Gene Polymorphisms and Venous Thromboembolism in Koreans |
236 | (±¹¿Ü)SCIE | STING signaling is a potential immunotherapeutic target in colorectal cancer |
235 | (±¹¿Ü)SCI | STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade |
234 | (±¹¿Ü)±âŸ | IL-27 Enhances IL-15/IL-18-mediated Activation of Human Natural Killer Cells |
Copyright ¨Ï chamc, All rights reserved.